| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |